Open Journal Systems

Multiple Tumor Markers Detection for Correlation Diagnosis of Ovarian Cancer

Reubina Wadee (The Medical Oncology Centre of Rosebank, Johannesburg, South Africa)
Safa I.H Taha (Radiation Medicine Program, Stronach Regional Cancer Center, Newmarket, Canada)

Abstract

The contents of serum CA125, alpha-fetoprotein (AFP) and CA199 and their diagnostic value in ovarian cancer were analyzed in this study. Firstly, 80 patients with ovarian malignant tumors from June 2019 to June 2020 in our hospital were included in the study group, and 80 patients with benign ovarian tumors were included in the control group during the same period. Serum levels and positive rates of CA125, AFP and CA199 were detected in both study group and control group. The expression levels of CA125, AFP and CA199 in the study group were all higher than those in the control group (P <0.05). The positive rate of AFP, CA199 and CA125 was 33.75%, 47.50% and 91.25% in study group, respectively. The joint detection positive rate was 92.50%. However, . The positive rate of CA125, AFP and CA199 was 23.75%, 0% and 11.25% in control group, and the joint detection positive rate was 28.75%. The positive rates of all indexes and the positive rates of comprehensive detection in the study group were higher than that in the control group (P < 0.05). Therefore, serum CA125, AFP and CA199 can be used as important indicators for the diagnosis of ovarian cancer.

Keywords

Tumor markers; Joint diagnosis; Ovarian cancer

Full Text:

PDF

References

Markman, M. Second-line treatment of ovarian cancer.[J]. Oncologist, 2000, 5(1):26-35.

King M C , Marks J H , Mandell J B . Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2[J]. ence, 2003, 302(5645):643-646.

A C M , A S W , B J B , et al. Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership[J]. Gynecologic Oncology, 2012, 127( 1):75-82.

Armstrong D K , Bundy B , Wenzel L , et al. Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer[J]. New England Journal of Medicine, 2006, 354(1):34-43.

Hasanbegovic L , Sljivo N . Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo[J]. Materia Socio-Medica, 2018, 30(1):15-19.

Su H Y , Lai H C , Lin Y W , et al. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer[J]. International Journal of Cancer, 2010, 124(2):387-393.

Xia B , Yang S , Liu T , et al. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6[J]. Molecular Cancer, 2015, 14(1):1-13.

Belisle J A , Arens J A , Migneault M , et al. The Role of the Ovarian Tumor Marker CA125 (MUC16) in the Suppression of Human Immune Responses[J]. Journla of Immunotherapy, 2005, 28(6):635-636.

Speeckaert M M , Speeckaert R , Delanghe J R . Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker.[J]. Advances in Clinical Chemistry, 2013, 59:1-21.

Patankar M S , Jing Y , Morrison J C , et al. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125[J]. Gynecologic Oncology, 2005, 99(3):704-713.

He Z , Gao N , Jin W . Determination of tumor marker CA125 by capillary electrophoretic enzyme immunoassay with electrochemical detection[J]. Analytica Chimica Acta, 2003, 497(1-2):75-81.

Hassan S O A . Monitoring Ovarian Cancer patients during chemoteraphy and follow-up with serum tumor marker CA125[J]. Danish Medical Journal, 2017, 65(4).

Wang H Z , Wang H Y , Liang R Q , et al. Detection of Tumor Marker CA125 in Ovarian Carcinoma Using Quantum Dots[J]. Acta Biochim Biophys Sin, 2004, 36(010):681-686.

Yu H . Reference intervals for gastrointestinal tumor markers (AFP, CEA, CA199 and CA724) in healthy adults of Han nationality in Chongqing by Roche ECLIA system[J]. Scandinavian Journal of Clinical and Laboratory Investigation, 2019:1-7.

Maximilian Schöniger-Hekele MD, Christian Müller MD. The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis[J]. Dig Dis, 2006, 51(2):338-345.

Huanbo C , Wei Z , Laboratory D O . CA724,CEA,CA242,CA199 Tumor Markers Joint Inspection in Gastric Carcinoma Diagnosis Value of[J]. China & Forgn Medical Treatment, 2015.

Kurman R J , Scardino P T , Mcintire K R , et al. Cellular localization of alpha‐fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. A new approach to classification utilizing tumor markers[J]. Cancer, 2015, 40(5):2136-2151.

DOI: http://dx.doi.org/10.30564/amor.v5i2.238

Refbacks

There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



Remember me